Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA
about
sameAs
TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behaviorHepatic falciform ligament clear cell myomelanocytic tumor: A case report and a comprehensive review of the literature on perivascular epithelioid cell tumorsHuman pigmentation genes under environmental selectionA polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathwayGenome-wide association studies of pigmentation and skin cancer: a review and meta-analysisA genome-wide association study identifies novel alleles associated with hair color and skin pigmentation.Association of interferon regulatory factor 4 gene polymorphisms rs12203592 and rs872071 with skin cancer and haematological malignancies susceptibility: a meta-analysis of 19 case-control studies.IRF4 variants have age-specific effects on nevus count and predispose to melanoma.A germline variant in the interferon regulatory factor 4 gene as a novel skin cancer risk locus.Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC)Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignanciesImmunohistochemistry in melanocytic proliferative lesions.Regulation of telomerase activity by interferon regulatory factors 4 and 8 in immune cells.Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project.Immunohistochemistry in the diagnosis of cutaneous neoplasms.Use of immunohistochemistry in the diagnosis of melanocytic lesions: applications and pitfalls.LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required.Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells.Immunohistochemistry: relevance in dermatology.Plasmacytoid melanoma of the urinary bladder and lymph nodes with immunohistochemical expression of plasma cell markers revealing primary esophageal melanoma.Perivascular epithelioid cell tumor arising in the sacrum: a case report.Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.IRF4 rs12203592 functional variant and melanoma survival.Desmoplastic melanoma may mimic a cutaneous peripheral nerve sheath tumor: Report of 3 challenging cases.Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.Whole-genome sequencing reveals selection signatures associated with important traits in six goat breeds.
P2860
Q24299955-3A440E05-AC31-4CFF-9329-DBD2611C7F64Q26772169-0F69031E-8679-433F-B6DA-7D8208ED6E20Q26865756-4AAA3867-A78A-4178-B0AD-D297DA194454Q28302540-F1270367-061C-4C86-86C5-C9C20DE7AD64Q28744574-C538F0D7-725B-4577-ADCE-E9B5DB564B5BQ33335147-EC655D12-2BC3-4D9E-8D95-A0611B07ACEDQ33761040-F45D567E-5F64-4CCA-9009-CB4B4A847E4CQ33960494-2A211DBA-3DA7-4918-91CF-DB16C88E143AQ34812433-4FF0314C-9838-4B89-9246-A25BEEF25983Q35243407-CB7DBD6C-BEB6-47B7-B76F-828E2913A518Q35245799-B4B6F9D0-F71C-44F9-8C6A-CA3E246ED702Q35798186-74CFE247-A290-4912-9336-1317A2BE0929Q37072135-0C31CE46-FECA-4177-A149-09E89D76428AQ37103054-83BC00CE-7863-46D9-96DA-2B84CAB210B0Q37353536-DFE548FD-FB59-4927-8573-A750B76D3FA6Q37384289-67100D21-5918-4B57-972F-CE00F0847D67Q37658770-C6EEFA67-7E68-4380-9F48-5BC7A69FE75EQ37771960-FF4F2C29-58DB-4B97-AE21-9AB5860F0C7DQ38732564-354DEE0B-E51D-422F-9E6B-AFF032ACB8B5Q39134387-DD3CB497-4503-4342-902C-5807BEC262DBQ41006365-259012C3-97CA-4F1B-9452-9B2D4ED5177FQ41589074-C58BF36F-EDC5-477D-928E-94C4A400BE5CQ42068448-3303E425-2F8F-4ED4-977D-ED45B0434E55Q42513019-FC04DECB-AC73-45DC-A60A-FFADFE5F2C61Q46955817-1388D166-870E-425A-9C43-F60F0B314076Q50218628-FDEB38D5-D147-45B7-9D40-1D039C98A226Q52881652-84C4C602-038E-4123-A895-426988D8309DQ53089324-CFCA9C1A-1BD6-492A-A2C2-AA8A49D8637FQ53742406-3F3227B1-26EC-4673-B652-1A94F2D45428Q55709465-40970AF0-BFAE-4149-8ADA-5DCA6468A9AD
P2860
Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@ast
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@en
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@nl
type
label
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@ast
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@en
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@nl
prefLabel
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@ast
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@en
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@nl
P2093
P2860
P1433
P1476
Expression of the B-cell proli ...... 100, gp100 (HMB45), and MelanA
@en
P2093
Jeff D Harvell
Robert V Rouse
Uma Sundram
Yasodha Natkunam
P2860
P304
P356
10.1097/01.MP.0000081726.49886.CF
P407
P577
2003-08-01T00:00:00Z
P5875
P6179
1051851764